Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation

被引:22
|
作者
Hwang, WJ
Yao, WJ
Wey, SP
Shen, LH
Ting, G
机构
[1] Natl Cheng Kung Univ, Dept Nucl Med, Coll Med, Tainan 704, Taiwan
[2] Natl Cheng Kung Univ, Dept Neurol, Coll Med, Tainan 704, Taiwan
[3] Inst Nucl Energy Res, Lungtan 32500, Taiwan
关键词
Parkinson's disease; dopamine D2 receptor; (123)l-IBZM SPECT;
D O I
10.1159/000047962
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to evaluate the contribution of the postsynaptic mechanism to the development of motor fluctuation in advanced Parkinson's disease (PD). We used I-123-iodobenzamide single-photon emission computed tomography to measure the striatal dopamine D2 receptor densities in early levodopa-naive PD, chronic PD with stable levodopa response, and advanced PD with fluctuating levodopa response. The basal ganglia/frontal cortex ratios at both hemispheres were calculated and averaged. PD patients with fluctuating levodopa response showed a significant decrease in striatal dopamine D2 receptor densities compared to those with early (1.57 +/- 0.20 vs. 1.77 +/- 0.12, p = 0.009) or chronic stable PD (1.57 +/- 0.20 vs. 1.77 +/- 0.10, p = 0.024). We conclude that the decreased D2 receptor densities in advanced PD reduced the 'safety factor' for synaptic transmission and contributed to the development of motor fluctuation. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 50 条
  • [1] Is stimulation of D1 and D2 dopamine receptors important for optimal motor functioning in Parkinson's disease?
    Jenner, PG
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 : S3 - S11
  • [2] Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study
    V. Kaasinen
    S. Aalto
    K. NÅgren
    J. Hietala
    P. Sonninen
    J. O. Rinne
    Journal of Neural Transmission, 2003, 110 : 591 - 601
  • [3] Extrastriatal dopamine D2 receptors in Parkinson's disease:: a longitudinal study
    Kaasinen, V
    Aalto, S
    Någren, K
    Hietala, J
    Sonninen, P
    Rinne, JO
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (06) : 591 - 601
  • [4] Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients
    Politis, Marios
    Wilson, Heather
    Wu, Kit
    Brooks, David J.
    Piccini, Paola
    NEUROIMAGE-CLINICAL, 2017, 16 : 455 - 460
  • [5] Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease
    Kaasinen, V
    Aalto, S
    Någren, K
    Rinne, JO
    MOVEMENT DISORDERS, 2004, 19 (11) : 1348 - 1351
  • [6] Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease -: A [11C]-raclopride PET study
    Thobois, S
    Fraix, V
    Savasta, M
    Costes, N
    Pollak, P
    Mertens, P
    Koudsie, A
    Le Bars, D
    Benabid, AL
    Broussolle, E
    JOURNAL OF NEUROLOGY, 2003, 250 (10) : 1219 - 1223
  • [7] Beta band modulation by dopamine D2 receptors in the primary motor cortex and pedunculopontine nucleus in a rat model of Parkinson's disease
    Wang, Xuenan
    Li, Min
    Xie, Jinlu
    Chen, Dadian
    Geng, Xiwen
    Sun, Shuang
    Liu, Bo
    Wang, Min
    BRAIN RESEARCH BULLETIN, 2022, 181 : 121 - 128
  • [8] Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
    Deutschlaender, Angela
    la Fougere, Christian
    Boetzel, Kai
    Albert, Nathalie L.
    Gildehaus, Franz-Josef
    Bartenstein, Peter
    Xiong, Guoming
    Cumming, Paul
    NEUROIMAGE-CLINICAL, 2016, 12 : 41 - 46
  • [9] Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?
    Linazasoro, G.
    Van Blercom, N.
    Ugedo, L.
    Ortega, J. A. Ruiz
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (03) : 431 - 441
  • [10] [18F] fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease
    Stark, Adam J.
    Smith, Christopher T.
    Petersen, Kalen J.
    Trujillo, Paula
    van Wouwe, Nelleke C.
    Donahue, Manus J.
    Kessler, Robert M.
    Deutch, Ariel Y.
    Zald, David H.
    Claassen, Daniel O.
    NEUROIMAGE-CLINICAL, 2018, 18 : 433 - 442